tiprankstipranks
Trending News
More News >

Biome Australia Ltd Partners with FaBA to Advance Probiotic Development

Story Highlights
Biome Australia Ltd Partners with FaBA to Advance Probiotic Development

Confident Investing Starts Here:

The latest update is out from Biome Australia Ltd ( (AU:BIO) ).

Biome Australia Ltd has announced a new co-investment agreement with Australia’s Food and Beverage Accelerator (FaBA) to develop its Lactobacillius plantarum BMB18 probiotic strain. The partnership, supported by significant government funding, allows Biome to retain full ownership of any intellectual property developed and potentially reduce future R&D costs, bolstering its positioning in the microbiome health industry.

More about Biome Australia Ltd

Biome Australia Ltd is a microbiome health company engaged in the development of probiotic strains. The company focuses on creating innovative solutions in the health sector, particularly around the modulation of immune responses, inflammation reduction, and maintaining intestinal health.

YTD Price Performance: -2.54%

Average Trading Volume: 571,053

Technical Sentiment Consensus Rating: Sell

See more data about BIO stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App